Conjugation of latent membrane protein (LMP)-2 epitope to gold nanoparticles as highly immunogenic multiple antigenic peptides for induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses in vitro

Bioconjugate Chemistry

Volumn 20, Issue 1, 2009, Pages 24-31

  Cheung, Wai Hung ^a,b   Chan, Vera Sau Fong ^b,c   Pang, Heung Wing ^a   Wong, Man Kin ^a   Guo, Zhi Hong ^d   Tam, Paul Kwong Hang ^b   Che, Chi Ming ^a   Lin, Chen Lung ^b,c   Yu, Wing Yiu ^a,d  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; CHEMICAL ACTIVATION; CYTOLOGY; EPITOPES; GOLD NANOPARTICLES; METAL NANOPARTICLES; SURFACE PLASMON RESONANCE; T-CELLS; ULTRAVIOLET VISIBLE SPECTROSCOPY; VIRUSES;

CYTOTOXIC T LYMPHOCYTES; EPSTEIN-BARR VIRUS; HIGH INCIDENCE; HUMAN LEUKOCYTE ANTIGEN; IN-VITRO; MEMBRANE PROTEINS; MULTIPLE ANTIGENIC PEPTIDE; NASOPHARYNGEAL CARCINOMA; PEPTIDE EPITOPES; SOUTHEAST ASIA;

PEPTIDES;

ACETYLCYSTEINE; ANTIGENIC PEPTIDE; EPITOPE; GAMMA INTERFERON; GOLD NANOPARTICLE; HLA A11 ANTIGEN; LATENT MEMBRANE PROTEIN 2; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGENICITY; ARTICLE; CAPPING PHENOMENON; CONJUGATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSPOT ASSAY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; NONHUMAN; PEPTIDE SYNTHESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN INDUCTION; ROOM TEMPERATURE; SURFACE PLASMON RESONANCE; ULTRAVIOLET SPECTROSCOPY;

HUMAN HERPESVIRUS 4;

EID: 61849144830     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc800167q     Document Type: Article

References (49)

1. Young, L. S., and Rickinson, A. B. (2004) Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4, 757-768.
2. Rickinson, A. B., and Moss, D. J. (1997) Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15, 405-431.
3. Straathof, K. C. M., Bollard, C. M., Popat, U., Huls, M. H., Lopez, T., Morriss, M. C, Gresik, M. V., Gee, A. P., Russell, H. V., Brenner, M. K., Rooney, C. M., and Heslop, H. E. (2005) Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes. Blood 105, 1898-1904.
4. Rickinson, A. B. and Kieff, E. (1996) Epstein-Barr Virus, Fields Virology (Fields, B. N. and Knipe, D. M.) pp 2397-2446, Lippincott-Raven Publishers, Philadelphia.
5. Tomkinson, B., Robertson, E., and Kieff, E. (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67, 2014-2025.
6. Petti, L., and Kieff, E. (1988) A sixth Epstein-Barr virus nuclear protein (EBNA3B) is expressed in latently infected growth-transformed lymphocytes. J. Virol. 62, 2173-2178.
7. Humme, S., Reisbach, G., Feederle, R., Delecluse, H.-J., Bousset, K., Hammerschmidt, W., and Schepers, A. (2003) The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc. Natl. Acad. Sci. U.S.A. 100, 10989-10994.
8. Hart, D. N. J., Jackson, D., and Nestle, F. (2002) Dendritic Cells and Cancer: Prospects for Cancer Vaccination, Cancer Immune Therapy (Walden, G. S. A. P., Ed.) pp 179-203, Wiley-VCH, Weinhem, Germany.
9. Banchereau, J., and Palucka, A. K. (2005) Dendritic Cells as Therapeutic vaccines aganist cancer. Nat. Rev. Immunology 296, 296-306.
10. Celluzzi, C. M, Mayordomo, J. I., Storkus, W. J., Lotze, M. T., and Falo, L. D., Jr. (1996) Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283-87.
11. Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C, Falo, L. D., Melief, C. J., Ildstad, S. T., Kast, W. M., and Deleo, A. B. (1995) Bone marrow-derived dendritic cells pulsed with synthesis tumor peptides elicit protective and therapeutic antitumour immunity. Nat. Med. 1, 1297-1302.
12. Lin, C.-L., Lo, W.-F., Lee, T.-H., Ren, Y., Hwang, S.-L., Cheng, Y.-F., Chen, C.-L., Chang, Y.-S., Lee, S. P., Rickinson, A. B., and Tam, P. K. H. (2002) Immunization with Epstein-Barr virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regrression in patients with EBV-positive nasopharyngeal carcinoma. Cancer Res. 62, 6952-6958.
13. Millard, A. L., Ittelet, D., Schooneman, F., and Bernard, J. (2003) Dendritic cell KLH loading requirements for efficient CD4(+) T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines. Vaccine 21, 869-876.
14. Shimizu, K., Thomas, E. K., Giedlin, M., and Mule, J. J. (2001) Enhancement of tumor lysate-and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein. Cancer Res. 61, 2618-2624.
15. Schnurr, M., Galambos, P., Scholz, C., Then, F., Dauer, M., Endres, S., and Eigler, A. (2001) Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Cancer Res. 61, 6445-6450.
16. Na, I. K., Keilholz, U., Letsch, A., Bauer, S., Asemissen, A. M., Nagorsen, D., Thiel, E., and Scheibenbogen, C. (2007) Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cells. Cancer Immunol. Immunother. 56, 391-396.
17. Guan, H. H., Budzynski, W., Koganty, R. R., Krantz, M. J., Reddish, M. A., Rogers, J. A., Longenecker, B. M., and Samuel, J. (1998) Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses. Bioconjugate Chem. 9, 451-458.
18. Nakano, Y., Mori, M., Nishinohara, S., Takita, Y., Naito, S., Kato, H., Taneichi, M., Komuro, K., and Uchida, T. (2001) Surface-linked liposomal antigen induces IgE-selective unresponsiveness regardless of the lipid components of liposomes. Bioconjugate Chem. 12, 391-395.
19. Tanaka, Y., Kasai, M., Taneichi, M., Naito, S., Kato, H., Mori, M., Nishida, M., Maekawa, N., Yamamura, H., Komuro, K., and Uchida, T. (2004) Liposomes with differential lipid components exert differential adjuvanticity in antigen-liposome conjugates via differential recognition by macrophages. Bioconjugate Chem. 15, 35-40.
20. McCormick, A. A., Corbo, T. A., Wykoff-Clary, S., Palmer, K. E., and Pogue, G. P. (2006) Chemical conjugate TMV-peptide bivalent fusion vaccines improve cellular immunity and tumor protection. Bioconjugate Chem. 17, 1330-1338.
21. Defoort, J.-P., Nardelli, B., Huang, W., Ho, D. D., and Tarn, J. P. (1992) Macromolecular assemblage in the design of a synthetic AIDS vaccines. Proc. Natl. Acad. Sci. U.S.A. 89, 3879-3883.
22. Olive, C, Toth, I., and Jackson, D. (2001) Technological advances in antigen delivery and synthetic peptide vaccine development strategies. Mini Rev. Med. Chem. 1, 429-438.
23. Chiellini, F., Piras, A. M., Errico, C, and Chiellini, E. (2008) Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications. Nanomedicine 3, 367-393.
24. Murakami, T., and Tsuchida, K. (2008) Recent advances in inorganic nanoparticle-based drug delivery systems. Mini Rev. Med. Chem. 8, 175-83.
25. Thassu, D., Deleers, M., and Pathak, Y. (2007) Nanoparticulate Drug Delivery Systems (Thassu, D., Deleers, M., and Pathak, Y., Eds.) pp 1-32, Informa Healthcare, New York.
26. Pridgen, E. M., Langer, R., and Farokhzad, O. C. (2007) Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine 2, 669-680.
27. Amrite, A. C, and Kompella, U. B. (2006) Nanoparticle Technology for Drug Delivery (Gupta, R. P., and Kompella, U. B., Eds.) pp 319-360, Taylor & Francis, New York.
28. Hong, S., Ackerman, A. L., Cody, V., Giodini, A., Hinson, E. R., Cresswell, P., Edelson, R. L., Saltzman, W. M., and Hanlon, D. J. (2006) Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 117, 78-88.
29. Bradley, J. S., and Schmid, G. (2004) Noble Metal Nanoparticle, Nanoparticles: From Theory to Application (Schmid, G., Ed.) pp 186-199, Wiley-VCH, Weinheim, Germany.
30. Daniel, M. C, and Astruc, D. (2004) Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 104, 293-346.
31. de la Fuente, J. M., Berry, C. C, Riehle, M. O., and Curtis, A. S. G. (2006) Nanoparticle Targeting at Cells. Langmuir 22, 3286-3293.
32. Yguerabide, J., and Yguerabide, E. E. (1998) Light-scattering submicroscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applications: I. Theory. Anal. Biochem. 262, 137-156.
33. Yguerabide, J., and Yguerabide, E. E. (1998) Light-scattering submicroscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applications: II. Experimental characterization. Anal. Biochem. 262, 157-176.
34. Thaxton, C. S., and Mirkin, C. A. (2004) DNA-Gold- Nanoparticle Conjugates, Nanobiotechnology: Concepts, Applications and Perspectives (Niemeyer, C. M., and Mirkin, C. A., Eds.) pp 288-207, Wiley-VCH, Weinheim, Germany.
35. Schultz, S., Smith, D. R., Mock, J. J., and Schultz, D. A. (2000) Single-target molecule detection with nonbleaching multicolor optical immunolabels. Proc. Natl. Acad. Sci. U.S.A. 97, 996-1001.
36. Taton, T. A., Mirkin, C. A., and Letsinger, R. L. (2000) Scanometric DNA array detection with nanoparticle probes. Science 289, 1757-1760.
37. Chan, W. C., and White, P. D. (2000) Basic Procedures, Fmoc Solid Phase Peptide Synthesis: A Practical Approach (Chan, W. C., and White, P. D., Eds.) pp 41-76, Oxford University Press, New York.
38. Frens, G. (1973) Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat. Phys. Sci. 241, 20-22.
39. Plebanski, M. (2000) Preparation of Lymphocytes and Identification of Lymphocytes Subpopulations, Lymphocytes: A Practical Approach (Rowland-Jones, S. L., and McMichael, A. J., Eds.) pp10-12, Oxford University Press, New York.
40. Gilliet, M. F., and Nestle, F. O. (2001) Generation of Blood-Derived Human Dendritic Cells for Antitumor Immunotherapy. Sendritic Clee Protocols (Robinson, S. P., and Stagg, A. J., Eds.) pp 297-306, Humana Press, Totowa, NJ.
41. Schlager, S. I., and Adams, A. C. (1983) Uses of dyes and radioisotopic markers in cytotoxicity tests, in. Methods Enzymol. 93, 233-245.
42. Geijtenbeek, T. B. H., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Adema, G. J., van Kooyk, Y., and Figdor, C. G. (2000) Identification of DC-SIGN, a novel dendritic cell- specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575-585.
43. Redchenko, I. V., and Rickinson, A. B. (1999) Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded dendritic cells. J. Virol. 73, 334-342.
44. Imanishi, T., Alaza, T., and Kimura, A. (1992) W15.1 Reference Tables, HLA-1991 (Tsuji, K., Aizawa, M., and Sasazuki, T., Eds.) pp 1066, Oxford University Press, Oxford.
45. Lee, T. D., Zhao, T. M., Mickey, R., Sun, Y. P., Lee, G., Song, C. X., Cheng, D. Z., Zhou, S., Ding, S. Q., and Cheng, D. X. (1988) The polymorphism of HLA antigens in the Chinese. Tissue Antigens 32, 188-208.
46. Chan, W. K., Ho, C. M., Wong, M. K., and Che, C. M. (2006) Oxidative amide synthesis and N-terminal α-amino group ligation of peptides in aqueous medium. J. Am. Chem. Soc. 128, 14796-14797.
47. Levy, R., Thanh, N. T. K., Doty, R. C., Hussain, I., Nichols, R. J., Schiffrin, D. J., Brust, M., and Fernig, D. G. (2004) Rational and combinatorial design of peptide capping ligands for gold nanoparticles. J. Am. Chem. Soc. 126, 10076-10084.
48. Gamero, A. M., Hodge, D. L., Reynolds, D. M., Rodriguez-Galan, M. C., Mohamadzadeh, M., and Young, H. A. (2006) The Interferon-[Gamma]: Gene and Protein Structure, Transcription Regulation, and Actions, The Interferons: Characterizatoin and Application (Meager, A., Ed.) pp 85-112, Wiley-VCH, Weinheim, Germany.
49. Khanna, R., and Burrows, S. R. (2000) Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases. Ann. Rev. Microbiol. 54, 19-48.